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Abstract
In September 2015, the Israel National Institute for Health Policy Research (NIHP) organized a workshop to address
the hopes and challenges of Big Data in healthcare in the Israeli context. The paper provides an overview of the
challenges and hopes raised by data driven science and Big Data, along with a summary of Israel’s strengths and
weaknesses regarding Big Data, as discussed by the speakers in the course of the conference. It concludes with
some hints on how Israel’s advantages in this field might be leveraged.
Background
In September 2015, the Israel National Institute for
Health Policy Research (NIHP) organized a workshop to
address the hopes and challenges of Big Data in health-
care in the Israeli context. The workshop, chaired by
Ronni Gamzu, was a unique occasion to allow fruitful
discussions between decision makers, researchers, and
care providers, and prominent national and international
experts in the field. The participants represented most
sectors of health, governmental agencies, and industry.
This paper reports the personal view and understand-
ings of the authors—the conference chairperson, and
one of the conference’s invited speakers from abroad.
The intention of this paper is to present a short over-
view of Big Data in health and its challenges, as well as
some ideas for the future. It is also an attempt to provide
an external insight on the situation of Big Data in Israel
and action plans that should be undertaken.
Big Data in health
According to the Health 2020 report of WHO [1],
healthcare systems in the 21st century are on an unsus-
tainable course. Maximizing health through all stages of
life is critical, and good health is an asset and a source
of economic and social stability. Good health is a global
capital resource and can no longer be seen as the
outcome of one sector alone. Sustainable health is the
product of numerous determinants across all parts of life
(including the environment, sanitation, exposure factors,
and lifestyle), as well as collaborative efforts across all
parts of society. In order to progress towards a better
understanding of health determinants, triggers of dis-
eases and innovative approaches for prevention and care,
new paradigms for research and policy makers are
needed. Data driven science and data driven decision
making is one of the most promising way to achieve it
[2]. It has already demonstrated a significant impact on
providers’ behaviour [3].
The Feb 2010 edition of “The Economist” introduces
the concept of “The Data Deluge” [4]. The resulting ex-
ponential growth in data quantities far outpaces the cap-
ability of human being to cope, so that the data are
largely unexploited. This is true for almost all aspects of
human activities, such as cell phones activity, mobility,
finance and economy, supply chains, environmental
data, etc. It is true in health when it comes to data about
patients and citizens, such as electronic health records
(EHR) or the quantified self, biobanks and genomics, im-
ages, etc. It is also true in the knowledge produced by
humans, and especially in medicine. The number of sci-
entific publication indexed in PubMed exceeded 22 mil-
lion at the end of 2014 [5] (Fig. 1) and continues to
grow at a rapid pace.
Big Data is expected to provide significant benefits for
individuals, such as in personalized medicine, but also
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for healthcare systems. The next generation of health-
care systems will need to exploit the ever-increasing
quantities of complex, massively multivariate data con-
cerning all aspects of health determinants, patient care,
and outcomes that are starting to be routinely acquired
and stored, throughout the life of each individuals of a
population. In 2005, in response to its earlier findings in
To Err is Human [6] and Crossing the Quality Chasm
[7], the Institute of Medicine (IOM) introduced the con-
cept of Learning Healthcare System. This concept has
subsequently evolved into a broader concept of a learn-
ing health system, as an ecosystem where all stake-
holders can securely, effectively and efficiently
contribute, share and use data to create knowledge and
support effective decision-making, leading to improved
health outcomes.
There are a growing number of examples of citi-
zens and patients starting to benefits from personal-
ized medicine, such as in pharmacogenomics [8].
The hopes and promises to improve health and care
outcomes significantly by allowing the development
of citizen- and patient-specific probabilistic health
models open the door to personalised medicine.
Data integration across spatial scales, from the mo-
lecular to the population level, and across temporal
scales, from genomics to lifestyle, is one of the key chal-
lenges for exploiting these massive, disparate datasets in
health.
The definitions and realities of Big Data are still the
object of discussions and debates. Big Data is a broad
term that designates datasets usually characterized by
their large size and high complexity, thus challenging
traditional data analytics. All aspects of data manage-
ment are involved, from data acquisition and capture,
through the stages of storage, transfer, access and
sharing, models for data representation and semantic
of the data, curation or quality management, analytics
or learning, visualization or human interactions, inter-
pretation and finally the capacity to support decisions
(which includes reliability and accuracy).
The Big Data’s term originates in 2001 with the three
Vs defined by Doug Laney [9]: Volume, Velocity, and
Variety. In his original vision, Doug Laney considered:
1. (V)olume for very large size;
2. (V)elocity for high bandwidth and I/O throughput;
3. (V)ariety for numerous datatypes and semantics.
Later, the (V)elocity also included real time analysis of
streams of data, such as real-time analytics on social net-
works activity. Slowly, up to eleven V were further
added, such as:
4. (V)alue: Data is becoming the new currency in the
economy. The vast amount of data available is used
to do targeted marketing, individual pricing, deep
learning, personalisation, predictive analytics,
amongst others;
5. (V)ariability: flows can be highly inconsistent with
periodic peaks;
6. (V)eracity: the reliability of data.
Dimensions
It is difficult to find metrics to characterize Big Data
properly, and there is no clearly defined ways of address-
ing this point. However, in a non-exhaustive approach,
five dimensions can be used:
 Extent, relates to the number of individuals, the
number of sources, the number of elements
Fig. 1 Yearly citation count from 1900–2012 MEDLINE/PubMed Baseline: 21,927,394 citations
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considered. Interoperability, privacy, or how data
can be linked are among the challenges raised by the
extent of elements;
 Deepness or granularity, represents how detailed are
the data considered, how much information is there
for each element. Representing data, models or
semantic are among the challenges raised;
 Density is the space between elements, or the
amount of links between elements or their data;
 Temporal length is duration considered. It is one of
the most difficult challenges. Big Data analytics
handles large volumes of data generated in short
time, but also have to handle data generated in a
long period. In the latter case, the problems of
handling the temporal variability of the semantics,
the evolution of the dataset, of external factors
influencing the data, etc. become crucial;
 Interpretability is the fact that the data can be used,
and how much, for the required purpose, sometimes
named “actionable data” in analogy to genomics.
This is finally the real value of the data and the
question the “autonomy” of the dataset: How far are
all information and knowledge required to “action”
the data available. In addition, to what extend shall
all of it be available on a computerized format.
Challenges
In order to gain all the potential hidden in the massive
amounts of data available, there are numerous chal-
lenges to address. They involve much more than the
challenges inherent in the usual data management and
analytic field; they raise important policy and regulatory
issues, with complex societal, ethical, technical and sci-
entific dimensions.
Privacy
One of the interesting aspects of Big Data is to connect
data from numerous sources. It can therefore create a
kind of virtual image of a person. This characteristic is
already being exploited for many widespread purposes
such as targeted marketing, personalized pricing, risk
evaluation for insurers, etc. It is much more complex in
health, but it is the goal of most ongoing initiatives in
the field. However, when it comes to health, building
trust is an essential aspect and it implies to provide citi-
zens with confidence in the whole system. Trust must be
built at all levels, from technical levels, such as security,
to the governance and transparency of the usage of the
data, such as consent management. The recently pub-
lished report “The Precision Medicine Initiative Cohort
Program” by the U.S. National Institute of Health, pro-
motes a very transparent, open, dynamic and proactive
vision of consent [10]. However, it must be kept in mind
that the data available on individuals are increasingly
able to unleash all aspects of life, including political, reli-
gious, racial, and behavioural and lifestyle determinants,
and raise new threats that will require new responses.
Regulatory and policy
Regulatory aspects have to deal with many aspects of Big
Data, at the fine edge between providing an enabling en-
vironment, while keeping a legal framework able to build
trust and protect the interests of all stakeholders. Find-
ing a good balance between protection and enabling is a
difficult challenge. However, there are many aspects
where the government can provide significant inputs.
The field of Big Data is recent, and there is a strong and
major shortage of experts in the field, of education
paths, of research and development, of outcome analysis.
All of these should be supported massively, and
promptly. Interoperability of data is a major challenge,
especially in health, which can only be addressed by fast
development and adoption of standards, especially in the
field of semantics. Numerous data sources are playing
critical role in health, such as studies raw data, drug
data, but also mobility, environment, exposition factors,
etc. While these data often exist, they are rarely avail-
able, and enforcing open data can leverage access to this
information.
Quality
Data quality is a recurrent problem in data management.
However, quality management takes on a new face in
the Big Data era. Numerous approaches and methods to
improve data quality have been used and sometimes
misused, in traditional data management and with Big
Data [11]. One of the interesting feature of having nu-
merous or streamed sources in Big Data is the frequent
impossibility to improve data quality at the source, such
as when dealing with information written in social net-
works. Another example is dealing with data quality over
a long period of capture or in distributed sources, when
there are variations of the quality in time and by source.
One of the most promising approaches is to replace data
curation by a continuous description of data quality,
which itself becomes a new data source.
Probabilistic decision support
Deep learning is one of the techniques allowing analytics
on large and unstructured data sources. However, this
type of approach, like many others, requires having a
well-balanced source of information. For example, when
building automatic learning using the medical literature,
it becomes crucial that all negative results be published
and rewarded equivalently to positive results. Otherwise,
probabilistic learning and thus decision support based
on large corpuses of published papers will be systematic-
ally biased. New ways of presenting results will have to
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be developed, such as description of the coverage of the
data sources, its reliability, etc. in order to be able to
evaluate the probability that the answers are correct and
evaluate the predictive value of the results.
Distributed analytics
One of the characteristic of health data is that it is usu-
ally difficult to build fully centralized repositories. This
is partly due to legal and regulatory frameworks, partly
due to the volume of some datasets, such as medical im-
ages; and finally due to the complexity and highly vari-
able of some structured datasets, such as formularies.
This aspect of health data is also emphasized in the One
million cohort project which recommends a hybrid data
and analytics architecture that leverages both centralized
data storage of core data while preserving federated ac-
cess to additional data [10]. However, distributed storage
implies also distributed analytics, and thus developing
new robust, reliable, and reproducible methodologies to
evaluate correlation and causality.
Data streams and complexity
Increasingly, the data will be in streams (the river of
data) rather than datasets (the lake of data). Most of the
traditional biostatistics and epidemiological analytics rely
on analyses of datasets, rather than analysing flows of
data in real-time. Complex probabilistic models, real-
time analytics such as bio-surveillance networks, raise
new challenges, as has been well shown with Google Flu
Trends [12, 13]. Good evaluation of these new models is
necessary, and, most probably, they will leverage trad-
itional models rather than replace them.
The hypothetic-deductive approach
The hypothetic-deductive approach is the traditional ap-
proach in epidemiology and clinical research: a hypoth-
esis is raised; it leads to a study design that tries to
minimize bias and confounding while maximizing
generalizability, a sample size calculation is carried out
to ensure enough power, and the results are allowed to
infirm or confirm the hypothesis. A second approach,
data mining, extends this approach at, usually, analysing
datasets to see if “something is in”, sometimes named
“fishing” the data. Big Data, when considered over long
period of time, introduces a third approach: how is it
possible to represent and store data and metadata in
order to allow the dataset to answer, in the future,
questions not known when the data were created and
collected. This is similar to long-term cohorts follow-
up: how to design the data management so that it
will be usable for future questions. The major chal-
lenge here is to enrich the metadata and use very
flexible models of representation.
“Unstructured” data
Increasing the amount of structured data is one of
the leitmotivs often heard when using EHRs because
unstructured data is considered as not usable for
clean analytics. In health, unstructured data is mostly
made of free text and narratives, then images and
signals. However, considering these sources as un-
structured is fallacious. These sources are, in fact,
highly structured. They are only poorly analysable
with computers. Human languages are highly evolved
and structured medium of communication. In
addition, they convey very dense and rich informa-
tion, and usually represent most of the information
available. Thus, they must be considered as such,
and important efforts invested in order to improve
the capacities to analyse them, such as natural lan-
guage processing, image recognition, etc.
Big Data and Israel
Throughout the workshop, it was very clear that
there are very important assets in Israel, especially
when it comes to data in the healthcare sector. The
data—“Big Data”—are available! A small number
(four) of large HMOs cover all the population, and
hospitals as well are consolidated in two main
groups: the governmental hospitals (approximately
half ) and those owed by Clalit HMO (almost a
third). In addition, HMO’s and hospitals have a long
history of computerized records. From the dimen-
sions of Big Data discussed above, this asset is one
of the richest in the world in five dimensions:
length, deepness, density and temporal length. The
latter is a precious advantage: More than 20 years of
history of capturing health data by most stakeholder
is a precious asset. A lot more can and should be
done with it [14].
However, having the data is not enough if it is not
made actionable, and the challenges discussed above
must be addressed. A priority to address is interoper-
ability, and very strong efforts should be undertaken
in order to promote the development and the
adoption of interoperability standards, especially for
semantics and data models. This goes along with the
need to develop competences in the complete chain
from data generation, to capture, and encoding, to
analytics and finally to the use of this asset in order
to leverage the healthcare system and promote health.
This will only be possible with strong interventions
mixing regulatory framework, sustained support and
incentives.
While there are top scientists, start-ups and SME’s
in the field of Big Data in Israel, there is a lack of
global awareness and competencies in the many
other fields involved. Introduction of the topic in the
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curriculum of care professionals, managers, decision
makers to name a few is still marginal. There are
only very few pre- and post-graduate specific educa-
tion paths. This lack of global expertise could pro-
duce a massive problem in a near future taken into
account the speed of the evolution of the field.
Table 1 summarizes these, and additional, strengths
and weaknesses that Israel brings to the field of Big
Data.
Conclusion
Israel’s current unique advantages might not be so
unique in a few years, when the new global players in
the field, and especially large companies such as
Amazon, Apple, Google or IBM, will team up in
more favourable environments. This can be in a con-
text less constrained with regulatory frameworks, or
better incentivized, or with improved penetration of
massive data production tools, such as quantified-self,
bio-banking, etc. These challenges can only be ad-
dressed if the philosophy in the healthcare system will
move from a competitive approach to a cooperative
and collaborative approach. This is true not only for
public-private partnerships, but also between aca-
demic centres or care providers. The Big Data area is
multidisciplinary in its essence, and it is wide by na-
ture. It requires converging efforts.
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